HOXA-AS2 and acute promyelocytic leukemia: HOXA-AS2, as a new 1048 bp lncRNA, was first reported to act as an inhibitor of apoptosis in NB4 promyelocytic leukemia cells treated with all-trans-retinoic acid19, and has been reported to be associated with many types of malignant tumors37.